MetaCap

enGene Therapeutics (ENGN) Options Chain

NASDAQ: ENGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.73-0.05 (-2.81%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Expiration date

Expiration
Mar 19, 2027
Days to expiration
158
Share price
$1.73
Put/call ratio (volume)
2.97
Expected move
±$0.0711
Open interest (C / P)
0 / 0

ENGN options summary

The ENGN options chain for the March 19, 2027 expiration lists 3 call and 2 put contracts, with 158 days until expiration. At-the-money implied volatility near the $2.00 strike is 6.3%, which implies the market expects a move of about ±$0.0711 (4.1%) in enGene Therapeutics stock by expiration. The most open interest sits at the $1.00 call (0 contracts) and the $1.00 put (0 contracts).

Summary generated from market data by MetaCap's automated system. Methodology

ENGN options chain · March 19, 2027

ENGN calls and puts by strike price. Shaded cells are in the money.
CallsPuts
LastBidAskStrikeBidAskLast
1.200.000.001.000.000.000.20
0.800.000.002.000.000.000.86
0.500.000.003.00———

In-the-money callsIn-the-money puts. IV = implied volatility, OI = open interest (contracts). Each contract covers 100 shares. Quotes delayed at least 15 minutes.

Frequently asked questions

What is ENGN's implied volatility?

At-the-money implied volatility for ENGN options expiring March 19, 2027 is about 6.3%, an annualized estimate of how much the market expects enGene Therapeutics stock to move.

How many ENGN option expiration dates are there?

ENGN has 4 listed expiration dates, from Oct 16, 2026 to Mar 19, 2027.

What does "in the money" mean?

A call is in the money when the strike price is below the current share price; a put is in the money when the strike is above it. In-the-money contracts have intrinsic value and are shaded in the table.

Related